UniFirst Declares Regular Cash Dividends
WILMINGTON, Mass., Jan. 10, 2017 (GLOBE NEWSWIRE) — The Board of Directors of UniFirst Corporation (NYSE:UNF) today declared regular quarterly cash dividends of $0.0375 per share (3.75 cents) on the Company’s Common Stock and $0.03 per share (3.0 cents) on the Company’s Class B Common Stock. Both dividends are payable on March 31, 2017, to... Read More →
REVISION – Hickok Incorporated Reports Fourth Quarter and Twelve Months Results
FINANCIAL HIGHLIGHTS Federal Hose acquisition contributes to income in the fourth quarter Favorable BP settlement results in $2.2 million in other income in the fourth quarter Fiscal year 2017 expected to be profitable CLEVELAND, Jan. 10, 2017 (GLOBE NEWSWIRE) — Hickok Incorporated (OTC Pink:HICKA), a Cleveland based supplier of products and services for the automotive,... Read More →
IPG Continues Support of UN Sustainable Development Goals
Holding Company Showcases Client Work Promoting Sustainable Water Efforts New York, NY – January 10, 2017 – Today, Interpublic Group (NYSE: IPG) released a new video in conjunction with the company’s support of UN Sustainable Development Goal #6, which the company adopted as part of the Common Ground Initiative launched this past summer at the... Read More →
Improved Academic Performance and Medication Rebound in Patients with ADHD Following the Use of Vayarin®, a Multi-Year, Real-World Retrospective Study
BALTIMORE, Jan. 10, 2017 (GLOBE NEWSWIRE) — Up to 75 percent of individuals with Attention Deficit Hyperactivity Disorder (ADHD) experience emotional dysregulation, according to Research in Developmental Disabilities. Emotional dysregulation is characterized by rapid, poorly controlled shifts in emotion, mood swings and behavioral outbursts. Studies have shown that individuals with ADHD and emotional dysregulation have... Read More →
On the amendments of a compulsory and final expression of a stock redemption offer’s prospectus of akciju sabiedrība “LATVIJAS TILTI”
Hereby akciju sabiedrība “LATVIJAS TILTI” informs that: – On the 5th of January 2017 offeror – SIA “LNK (Latvijas Novitātes Komplekss)” (registration number 40003000252, legal address: 15 Jana Dalina Street, Riga, LV-1013, Latvia) has amended the compulsory and final expression of the stock redemption offer’s prospectus of akciju sabiedrība “LATVIJAS TILTI”, that was confirmed by... Read More →
RedHill Biopharma Announces First Dosing in RHB-105 Supportive PK Studies Ahead of Confirmatory Phase III Study for H. pylori Infection
The first group of subjects have been dosed in a single-dose three-way crossover pharmacokinetic (PK) study with RHB-105 versus the active comparators in the confirmatory Phase III study and in a food-effect study with RHB-105 in healthy volunteers The confirmatory Phase III study with RHB-105 for H. pylori infection is planned to be initiated, subject... Read More →
CAPMAN PLC HAS ANNOUNCED THE PRELIMINARY RESULT OF THE SUBSEQUENT OFFER PERIOD OF THE EXCHANGE OFFER
Helsinki, Finland, 2017-01-10 14:30 CET (GLOBE NEWSWIRE) — Norvestia Oyj Stock Exchange Release 10 January 2017 at 15:30 This stock exchange release may not be published or distributed, in whole or in part, directly or indirectly, in the United States of America, Australia, Canada, Hong Kong, Japan, New Zealand, South Africa, or any... Read More →
Fiasp® (fast-acting insulin aspart) approved in Europe
Bagsværd, Denmark, 10 January 2017 – Novo Nordisk today announced that the European Commission has granted marketing authorisation for Fiasp® for the treatment of diabetes in adults. The authorisation covers all 28 European Union member states. Fiasp® is the brand name for fast-acting insulin aspart. Fiasp® provides improved mealtime and overall glucose control with a similar... Read More →
Chembio Completes Acquisition of Malaysia-based RVR Diagnostics
MEDFORD, N.Y., Jan. 10, 2017 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that the Company has completed the previously announced acquisition of RVR Diagnostics Sdn Bhd (RVR), a Malaysian, privately-held manufacturer and distributor of POC diagnostic tests for infectious diseases. In November 2016,... Read More →
Capital Bank Financial Corp. Sets Earnings Release and Conference Call Date for Fourth-Quarter 2016 Results
Charlotte, N.C., Jan. 10, 2017 (GLOBE NEWSWIRE) — Capital Bank Financial Corp. (Nasdaq: CBF) today announced that it will release its fourth-quarter 2016 financial results on Thursday, January 26, 2017, and management will host a conference call that day at 10:00 a.m. Eastern Time. Presentation materials related to the conference call will be available on... Read More →